{
    "info": {
        "nct_id": "NCT04134936",
        "official_title": "A Phase Ib, Open-label, Randomized Study to Assess Safety and Preliminary Efficacy of Tafasitamab in Addition to R-CHOP or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - First-MIND",
        "inclusion_criteria": "1. Age >18 years\n2. Histologically confirmed diagnosis of DLBCL, not otherwise specified (NOS)\n3. Tumor tissue for retrospective central pathology review and correlative studies must be provided.\n4. At least one bidimensionally measurable, PET positive disease site (greatest transverse diameter of ≥1.5 cm, greatest perpendicular diameter of ≥1.0 cm)\n5. Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2\n6. International Prognostic Index (IPI) status of 2 to 5\n7. Appropriate candidate for R-CHOP\n8. Left ventricular ejection fraction (LVEF) of ≥50% assessed by echocardiography or cardiac multi-gated acquisition (MUGA) scan\n9. Adequate hematologic, liver and renal function\n10. Females of childbearing potential (FCBP) must:\n\n    * not be pregnant\n    * refrain from breast feeding and donating oocyte\n    * agree to ongoing pregnancy testing\n    * commit to continued abstinence from heterosexual intercourse, or agree to use and be able to comply with the use of double-barrier contraception\n11. Males must:\n\n    * use an effective barrier method of contraception if sexually active with FCBP\n    * refrain from donating sperm\n12. In the opinion of investigator, the patient must be able and willing to receive adequate prophylaxis and/or therapy for thromboembolic events\n\nMajor\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Any other histological type of lymphoma according to World Health Organization (WHO) 2016 classification of lymphoid neoplasms, known double- or triple-hit lymphoma\n2. Transformed non-Hodgkin lymphoma (NHL) and/or evidence of composite lymphoma\n3. History of radiation therapy to ≥25% of the bone marrow or history of anthracycline therapy\n4. History of prior non-hematologic malignancy except for the following:\n\n   * Malignancy treated with curative intent and with no evidence of active disease present for more than 2 years before screening\n   * Adequately treated lentigo maligna melanoma without current evidence of disease or adequately controlled non-melanomatous skin cancer\n   * Adequately treated carcinoma in situ without current evidence of disease\n5. History of myocardial infarction ≤6 months, or congestive heart failure requiring use of ongoing maintenance therapy for life-threatening arrhythmias\n6. Patients with:\n\n   * positive test results for active hepatitis B and C\n   * known seropositive for or history of active viral infection with human immunodeficiency virus (HIV)\n   * known active bacterial, viral, fungal, mycobacterial, or other infection at screening\n   * known central nervous system (CNS) lymphoma involvement\n   * history or evidence of clinically significant cardiovascular, CNS and/or other systemic disease that would in the investigator opinion preclude participation in the study",
        "miscellaneous_criteria": "Major"
    },
    "inclusion_lines": [
        {
            "line": "1. Age >18 years",
            "criterions": [
                {
                    "exact_snippets": "Age >18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Histologically confirmed diagnosis of DLBCL, not otherwise specified (NOS)",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed diagnosis of DLBCL, not otherwise specified (NOS)",
                    "criterion": "DLBCL diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis confirmation method",
                            "expected_value": "histologically confirmed"
                        },
                        {
                            "requirement_type": "subtype",
                            "expected_value": "not otherwise specified (NOS)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Tumor tissue for retrospective central pathology review and correlative studies must be provided.",
            "criterions": [
                {
                    "exact_snippets": "Tumor tissue for retrospective central pathology review and correlative studies must be provided.",
                    "criterion": "tumor tissue",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. At least one bidimensionally measurable, PET positive disease site (greatest transverse diameter of ≥1.5 cm, greatest perpendicular diameter of ≥1.0 cm)",
            "criterions": [
                {
                    "exact_snippets": "At least one bidimensionally measurable, PET positive disease site",
                    "criterion": "disease site",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "PET positivity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "greatest transverse diameter of ≥1.5 cm",
                    "criterion": "disease site greatest transverse diameter",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "cm"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "greatest perpendicular diameter of ≥1.0 cm",
                    "criterion": "disease site greatest perpendicular diameter",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.0,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. International Prognostic Index (IPI) status of 2 to 5",
            "criterions": [
                {
                    "exact_snippets": "International Prognostic Index (IPI) status of 2 to 5",
                    "criterion": "International Prognostic Index (IPI) status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Appropriate candidate for R-CHOP",
            "criterions": [
                {
                    "exact_snippets": "Appropriate candidate for R-CHOP",
                    "criterion": "R-CHOP candidacy",
                    "requirements": [
                        {
                            "requirement_type": "appropriateness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Adequate hematologic, liver and renal function",
            "criterions": [
                {
                    "exact_snippets": "Adequate hematologic ... function",
                    "criterion": "hematologic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... liver ... function",
                    "criterion": "liver function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... renal function",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Females of childbearing potential (FCBP) must:",
            "criterions": [
                {
                    "exact_snippets": "Females of childbearing potential (FCBP)",
                    "criterion": "sex and reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* not be pregnant",
            "criterions": [
                {
                    "exact_snippets": "not be pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnancy",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Left ventricular ejection fraction (LVEF) of ≥50% assessed by echocardiography or cardiac multi-gated acquisition (MUGA) scan",
            "criterions": [
                {
                    "exact_snippets": "Left ventricular ejection fraction (LVEF) of ≥50%",
                    "criterion": "left ventricular ejection fraction (LVEF)",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "%"
                            }
                        },
                        {
                            "requirement_type": "assessment_method",
                            "expected_value": [
                                "echocardiography",
                                "cardiac multi-gated acquisition (MUGA) scan"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* refrain from breast feeding and donating oocyte",
            "criterions": [
                {
                    "exact_snippets": "refrain from breast feeding",
                    "criterion": "breast feeding",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "refrain from ... donating oocyte",
                    "criterion": "oocyte donation",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* agree to ongoing pregnancy testing",
            "criterions": [
                {
                    "exact_snippets": "agree to ongoing pregnancy testing",
                    "criterion": "pregnancy testing",
                    "requirements": [
                        {
                            "requirement_type": "agreement to ongoing testing",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* commit to continued abstinence from heterosexual intercourse, or agree to use and be able to comply with the use of double-barrier contraception",
            "criterions": [
                {
                    "exact_snippets": "commit to continued abstinence from heterosexual intercourse",
                    "criterion": "abstinence from heterosexual intercourse",
                    "requirements": [
                        {
                            "requirement_type": "commitment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "continued"
                        }
                    ]
                },
                {
                    "exact_snippets": "agree to use and be able to comply with the use of double-barrier contraception",
                    "criterion": "double-barrier contraception",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability to comply",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. Males must:",
            "criterions": [
                {
                    "exact_snippets": "Males must",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* use an effective barrier method of contraception if sexually active with FCBP",
            "criterions": [
                {
                    "exact_snippets": "use an effective barrier method of contraception",
                    "criterion": "contraception method",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "effective barrier method"
                        }
                    ]
                },
                {
                    "exact_snippets": "if sexually active with FCBP",
                    "criterion": "sexual activity with female of childbearing potential (FCBP)",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* refrain from donating sperm",
            "criterions": [
                {
                    "exact_snippets": "refrain from donating sperm",
                    "criterion": "sperm donation",
                    "requirements": [
                        {
                            "requirement_type": "abstinence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Major",
            "criterions": [
                {
                    "exact_snippets": "Major",
                    "criterion": "major medical condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "12. In the opinion of investigator, the patient must be able and willing to receive adequate prophylaxis and/or therapy for thromboembolic events",
            "criterions": [
                {
                    "exact_snippets": "the patient must be able ... to receive adequate prophylaxis and/or therapy for thromboembolic events",
                    "criterion": "ability to receive prophylaxis and/or therapy for thromboembolic events",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "the patient must be ... willing to receive adequate prophylaxis and/or therapy for thromboembolic events",
                    "criterion": "willingness to receive prophylaxis and/or therapy for thromboembolic events",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Adequately treated carcinoma in situ without current evidence of disease",
            "criterions": [
                {
                    "exact_snippets": "Adequately treated carcinoma in situ",
                    "criterion": "carcinoma in situ",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "adequately treated"
                        }
                    ]
                },
                {
                    "exact_snippets": "without current evidence of disease",
                    "criterion": "evidence of disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. History of radiation therapy to ≥25% of the bone marrow or history of anthracycline therapy",
            "criterions": [
                {
                    "exact_snippets": "History of radiation therapy to ≥25% of the bone marrow",
                    "criterion": "radiation therapy to bone marrow",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "extent",
                            "expected_value": {
                                "operator": ">=",
                                "value": 25,
                                "unit": "% of the bone marrow"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "history of anthracycline therapy",
                    "criterion": "anthracycline therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* known central nervous system (CNS) lymphoma involvement",
            "criterions": [
                {
                    "exact_snippets": "known central nervous system (CNS) lymphoma involvement",
                    "criterion": "central nervous system (CNS) lymphoma involvement",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "knowledge_status",
                            "expected_value": "known"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. History of myocardial infarction ≤6 months, or congestive heart failure requiring use of ongoing maintenance therapy for life-threatening arrhythmias",
            "criterions": [
                {
                    "exact_snippets": "History of myocardial infarction ≤6 months",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "congestive heart failure requiring use of ongoing maintenance therapy for life-threatening arrhythmias",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "requires_ongoing_maintenance_therapy_for_life_threatening_arrhythmias",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequately treated lentigo maligna melanoma without current evidence of disease or adequately controlled non-melanomatous skin cancer",
            "criterions": [
                {
                    "exact_snippets": "Adequately treated lentigo maligna melanoma without current evidence of disease",
                    "criterion": "lentigo maligna melanoma",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "adequately treated"
                        },
                        {
                            "requirement_type": "current evidence of disease",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "adequately controlled non-melanomatous skin cancer",
                    "criterion": "non-melanomatous skin cancer",
                    "requirements": [
                        {
                            "requirement_type": "disease control",
                            "expected_value": "adequately controlled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. History of prior non-hematologic malignancy except for the following:",
            "criterions": [
                {
                    "exact_snippets": "History of prior non-hematologic malignancy",
                    "criterion": "prior non-hematologic malignancy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Malignancy treated with curative intent and with no evidence of active disease present for more than 2 years before screening",
            "criterions": [
                {
                    "exact_snippets": "Malignancy treated with curative intent",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "treatment_intent",
                            "expected_value": "curative"
                        }
                    ]
                },
                {
                    "exact_snippets": "no evidence of active disease present for more than 2 years before screening",
                    "criterion": "active disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "duration_since_last_evidence",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Transformed non-Hodgkin lymphoma (NHL) and/or evidence of composite lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Transformed non-Hodgkin lymphoma (NHL)",
                    "criterion": "transformed non-Hodgkin lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of composite lymphoma",
                    "criterion": "composite lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "evidence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* history or evidence of clinically significant cardiovascular, CNS and/or other systemic disease that would in the investigator opinion preclude participation in the study",
            "criterions": [
                {
                    "exact_snippets": "history or evidence of clinically significant cardiovascular ... disease",
                    "criterion": "cardiovascular disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or evidence of clinically significant ... CNS ... disease",
                    "criterion": "CNS disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or evidence of clinically significant ... other systemic disease",
                    "criterion": "other systemic disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Any other histological type of lymphoma according to World Health Organization (WHO) 2016 classification of lymphoid neoplasms, known double- or triple-hit lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Any other histological type of lymphoma according to World Health Organization (WHO) 2016 classification of lymphoid neoplasms",
                    "criterion": "histological type of lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "classification",
                            "expected_value": "any type other than the one(s) specified by the study, per WHO 2016 classification"
                        }
                    ]
                },
                {
                    "exact_snippets": "known double- or triple-hit lymphoma",
                    "criterion": "double- or triple-hit lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* known seropositive for or history of active viral infection with human immunodeficiency virus (HIV)",
            "criterions": [
                {
                    "exact_snippets": "known seropositive for ... human immunodeficiency virus (HIV)",
                    "criterion": "HIV serostatus",
                    "requirements": [
                        {
                            "requirement_type": "seropositivity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of active viral infection with human immunodeficiency virus (HIV)",
                    "criterion": "HIV infection history",
                    "requirements": [
                        {
                            "requirement_type": "history of active infection",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [
        {
            "line": "Major",
            "criterions": [
                {
                    "exact_snippets": "Major",
                    "criterion": "major medical condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "6. Patients with:",
            "criterions": []
        },
        {
            "line": "* positive test results for active hepatitis B and C",
            "criterions": [
                {
                    "exact_snippets": "positive test results for active hepatitis B",
                    "criterion": "active hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "test result",
                            "expected_value": "positive"
                        }
                    ]
                },
                {
                    "exact_snippets": "positive test results for active hepatitis C",
                    "criterion": "active hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "test result",
                            "expected_value": "positive"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* known active bacterial, viral, fungal, mycobacterial, or other infection at screening",
            "criterions": [
                {
                    "exact_snippets": "known active bacterial ... infection at screening",
                    "criterion": "bacterial infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "known active viral ... infection at screening",
                    "criterion": "viral infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "known active fungal ... infection at screening",
                    "criterion": "fungal infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "known active mycobacterial ... infection at screening",
                    "criterion": "mycobacterial infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "known active ... other infection at screening",
                    "criterion": "other infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at screening"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}